CNB Bank - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,009 filers reported holding NOVARTIS A G in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.

Quarter-by-quarter ownership
CNB Bank ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,579,746
-2.3%
15,509
-3.2%
0.93%
-2.2%
Q2 2023$1,616,578
+5.2%
16,020
-4.1%
0.95%
+1.6%
Q1 2023$1,537,136
+4.5%
16,708
+3.1%
0.94%
+1.7%
Q4 2022$1,470,843
+19.1%
16,213
-0.3%
0.92%
+10.0%
Q3 2022$1,235,000
-8.6%
16,256
+1.7%
0.84%
-4.3%
Q2 2022$1,351,000
-10.8%
15,985
-7.3%
0.87%
+3.1%
Q1 2022$1,514,000
+4.4%
17,252
+4.1%
0.85%
+6.8%
Q4 2021$1,450,000
+6.5%
16,573
-0.5%
0.79%
-2.9%
Q3 2021$1,362,000
+1.3%
16,650
+12.9%
0.82%
-2.7%
Q2 2021$1,345,000
+6.6%
14,743
-0.2%
0.84%
-3.7%
Q1 2021$1,262,000
-7.2%
14,770
+2.6%
0.87%
-15.0%
Q4 2020$1,360,000
+18.3%
14,400
+8.9%
1.03%
+6.1%
Q3 2020$1,150,000
-9.3%
13,226
-8.9%
0.97%
-13.3%
Q2 2020$1,268,000
+11.6%
14,518
+5.4%
1.12%
-8.8%
Q1 2020$1,136,000
+5.7%
13,774
+21.4%
1.22%
+34.5%
Q4 2019$1,075,000
+23.4%
11,350
+13.2%
0.91%
+12.9%
Q3 2019$871,000
+18.2%
10,023
+24.2%
0.81%
+28.1%
Q2 2019$737,000
+10.5%
8,072
+16.3%
0.63%
+82.8%
Q1 2019$667,000
+19.1%
6,941
+6.3%
0.34%
-3.6%
Q4 2018$560,000
+16.9%
6,529
+17.5%
0.36%
+30.3%
Q3 2018$479,000
+15.1%
5,555
+0.8%
0.27%
+13.2%
Q2 2018$416,000
-5.0%
5,513
+1.8%
0.24%
-5.5%
Q1 2018$438,000
+1.4%
5,415
+5.2%
0.26%
-0.8%
Q4 2017$432,0005,1470.26%
Other shareholders
NOVARTIS A G shareholders Q1 2018
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 332,962$27,452,0007.32%
Mawer Investment Management Ltd. 7,721,327$636,623,0005.86%
Martin Investment Management, LLC 133,246$10,986,0005.56%
SCHARF INVESTMENTS, LLC 1,330,175$109,673,0005.48%
Hansberger Growth Investors, LP 46,663$3,847,0005.19%
Bain Capital Public Equity Management II, LLC 440,233$36,297,0004.25%
First Fiduciary Investment Counsel, Inc. 187,633$15,470,0004.10%
GARLAND CAPITAL MANAGEMENT INC 53,555$4,416,0004.02%
Lowell Blake & Associates Inc. 37,219$3,069,0003.94%
PRENTISS SMITH & CO INC 68,027$5,609,0003.89%
View complete list of NOVARTIS A G shareholders